Phamacopuncture and Dermal Application of Sebalgukhwa-san: Effects on Hair Growth in a Mouse Model of Alopecia

    Meiling Ji, Seong Chul Lim, Jae Soo Kim, Hyun Jong Lee, Yun Kyu Lee
    TLDR Sebalgukhwa-san (SGS) can help treat hair loss without liver toxicity.
    The study evaluated the effects of pharmacopuncture and dermal application of Sebalgukhwa-san (SGS) extracts on hair growth in an alopecia mouse model using 21 C57BL/6 mice. Results showed that both minoxidil (MNXD) and SGS treatments significantly improved hair growth, density, and thickness compared to the control group (p < 0.05). The number of hair follicles increased, although their size did not change. Protein expression related to hair growth showed increased levels of vascular endothelial growth factor and insulin-like growth factor-1, and decreased transforming growth factor-beta 1, but these changes were not statistically significant. SGS treatment did not exhibit liver toxicity. The study concluded that SGS could be beneficial for treating alopecia.
    View this study on e-jar.org →

    Cited in this study

    Related

      Common Dermatologic Conditions

      research Common Dermatologic Conditions

      14 citations ,   May 2014 in “Medical Clinics of North America”
      The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.
      Treatment of Hair Loss

      research Treatment of Hair Loss

      370 citations ,   September 1999 in “The New England Journal of Medicine”
      Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.